Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Submitted by
admin
on November 25, 2013 - 9:12am
Source:
Forbes
News Tags:
cholesterol
PCSK9 inhibitors
evolocumab
Amgen
Headline:
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Do Not Allow Advertisers to Use My Personal information
